176 related articles for article (PubMed ID: 20359839)
1. Efficacy and tolerability of levetiracetam in children with epilepsy.
Li J; Xiao N; Chen S
Brain Dev; 2011 Feb; 33(2):145-51. PubMed ID: 20359839
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
Krief P; Li Kan ; Maytal J
J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel C; Holthausen H; Kluger G
Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
Obeid M; Pong AW
Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
9. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.
Grosso S; Cordelli DM; Franzoni E; Coppola G; Capovilla G; Zamponi N; Verrotti A; Morgese G; Balestri P
Seizure; 2007 Jun; 16(4):345-50. PubMed ID: 17368928
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
[TBL] [Abstract][Full Text] [Related]
15. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam for people with mental retardation and refractory epilepsy.
Kelly K; Stephen LJ; Brodie MJ
Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
[TBL] [Abstract][Full Text] [Related]
17. Rapid dosage titration of levetiracetam in children.
Vaisleib II; Neft RA
Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
Coppola G; Mangano S; Tortorella G; Pelliccia A; Fels A; Romano A; Nardello R; Habetswallner F; Licciardi F; Operto FF; Pascotto A
Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
